IFN-β-mediated inhibition of IL-8 expression requires the ISGF3 components Stat1, Stat2, and IRF-9

Journal of Interferon and Cytokine Research

Volumn 28, Issue 1, 2008, Pages 13-23

  Laver, Travis ^a   Nozell, Susan E ^a   Benveniste, Etty N ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; INTERFERON REGULATORY FACTOR 9; INTERFERON STIMULATED GENE FACTOR 3; INTERLEUKIN 8; STAT1 PROTEIN; STAT2 PROTEIN;

ARTICLE; CONTROLLED STUDY; DNA BINDING; DNA RESPONSIVE ELEMENT; ENZYME INHIBITION; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

CELL LINE; GENE EXPRESSION REGULATION; HUMANS; INTERFERON-BETA; INTERFERON-STIMULATED GENE FACTOR 3, GAMMA SUBUNIT; INTERLEUKIN-8; PROMOTER REGIONS (GENETICS); RNA, MESSENGER; STAT1 TRANSCRIPTION FACTOR; STAT2 TRANSCRIPTION FACTOR; TETRADECANOYLPHORBOL ACETATE;

EID: 38649143119     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2007.0062     Document Type: Article

References (34)

1. Aoudjit F, Brochu N, Belanger B, Stratowa C, Hiscott J, Audette M. 1997. Regulation of intercellular adhesion molecule-1 gene by tumor necrosis factor-alpha is mediated by the nuclear factor-kappaB heterodimers p65/p65 and p65/c-Rel in the absence of p50. Cell Growth Differ 8:335-342.
2. Choi C, Xu X, Oh JW, Lee SJ, Gillespie GY, Park H, Jo H, Benveniste EN. 2001. Fas-induced expression of chemokines in human glioma cells: involvement of extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase. Cancer Res 61:3084-3091.
3. Darnell JE Jr, Kerr IM, Stark GR. 1994. Jak-Stat pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264:1415-1421.
4. Desbaillets I, Diserens AC, de Tribolet N, Hamou MF, Van Meir EG. 1997. Upregulation of interleukin 8 by oxygen-deprived cells in glioblastoma suggests a role in leukocyte activation, chemotaxis, and angiogenesis. J Exp Med 186:1201-1212.
5. Desbaillets I, Diserens AC, de Tribolet N, Hamou MF, Van Meir EG. 1999. Regulation of interleukin-8 expression by reduced oxygen pressure in human glioblastoma. Oncogene 18:1447-1456.
6. Hoffmann E, Dittrich-Breiholz O, Holtmann H, Kracht M. 2002. Multiple control of interleukin-8 gene expression. J Leukoc Biol 72:847-855.
7. Isaacs A, Lindenmann J. 1957. Virus interference. I. The interferon. Proc R Soc Lond B Biol Sci 147:258-267.
8. Kasahara T, Mukaida N, Yamashita K, Yagisawa H, Akahoshi T, Matsushima K. 1991. IL-1 and TNF-alpha induction of IL-8 and monocyte chemotactic and activating factor (MCAF) mRNA expression in a human astrocytoma cell line. Immunology 74:60-67.
9. Kelly JM, Porter AC, Chernajovsky Y, Gilbert CS, Stark GR, Kerr IM. 1986. Characterization of a human gene inducible by alpha- and beta-interferons and its expression in mouse cells. EMBO J 5:1601-1606.
10. Kovarik P, Mangold M, Ramsauer K, Heidari H, Steinborn R, Zotter A, Levy DE, Muller M, Decker T. 2001. Specificity of signaling by Stat1 depends on SH2 and C-terminal domains that regulate Ser727 phosphorylation, differentially affecting specific target gene expression. EMBO J 20:91-100.
11. Kunsch C, Rosen CA. 1993. NF-kappa B subunit-specific regulation of the interleukin-8 promoter. Mol Cell Biol 13:6137-6146.
12. Lau JF, Horvath CM. 2002. Mechanisms of type I interferon cell signaling and Stat-mediated transcriptional responses. Mt Sinai J Med 69:156-168.
13. Lee TH, Lee GW, Ziff EB, Vilcek J. 1990. Isolation and characterization of eight tumor necrosis factor-induced gene sequences from human fibroblasts. Mol Cell Biol 10:1982-1988.
14. Leung TH, Hoffmann A, Baltimore D. 2004. One nucleotide in a kappaB site can determine cofactor specificity for NF-kappaB dimers. Cell 118:453-464.
15. Ma Z, Chang MJ, Shah RC, Benveniste EN. 2005. Interferon-gamma-activated Stat1alpha suppresses MMP-9 gene transcription by sequestration of the coactivators CBP/p300. J Leukoc Biol 78:515-523.
16. Ma Z, Qin H, Benveniste EN. 2001. Transcriptional suppression of matrix metalloproteinase-9 gene expression by IFN-gamma and IFN-beta: critical role of Stat1 alpha. J Immunol 167:5150-5159.
17. Matsusaka T, Fujikawa K, Nishio Y, Mukaida N, Matsushima K, Kishimoto T, Akira S. 1993. Transcription factors NF-IL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. Proc Natl Acad Sci USA 90:10193-10197.
18. Mukaida N. 2003. Pathophysiological roles of interleukin-8/CXCL8 in pulmonary diseases. Am J Physiol Lung Cell Mol Physiol 284:L566-577.
19. Nozell S, Laver T, Patel K, Benveniste EN. 2006. Mechanism of IFN-beta-mediated inhibition of IL-8 gene expression in astroglioma cells. J Immunol 177:822-830.
20. Nozell S, Ma Z, Wilson C, Shah R, Benveniste EN. 2004. Class II major histocompatibility complex transactivator (CIITA) inhibits matrix metalloproteinase-9 gene expression. J Biol Chem 279:38577-38589.
21. Oliveira IC, Mukaida N, Matsushima K, Vilcek J. 1994. Transcriptional inhibition of the interleukin-8 gene by interferon is mediated by the NF-kappa B site. Mol Cell Biol 14:5300-5308.
22. Oliveira IC, Sciavolino PJ, Lee TH, Vilcek J. 1992. Downregulation of interleukin 8 gene expression in human fibroblasts: unique mechanism of transcriptional inhibition by interferon. Proc Natl Acad Sci USA 89:9049-9053.
23. Parker N, Porter AC. 2004. Identification of a novel gene family that includes the interferon-inducible human genes 6-16 and ISG12. BMC Genomics 5:8.1-8.11.
24. Platanias LC. 2005. Mechanisms of type-I- and type-II-interferon-mediated signaling. Nat Rev Immunol 5:375-386.
25. Qureshi SA, Leung S, Kerr IM, Stark GR, Darnell JE Jr. 1996. Function of Stat2 protein in transcriptional activation by alpha interferon. Mol Cell Biol 16:288-293.
26. Roebuck KA. 1999. Regulation of interleukin-8 gene expression. J Interferon Cytokine Res 19:429-438.
27. Schindler C, Fu XY, Improta T, Aebersold R, Darnell JE Jr. 1992. Proteins of transcription factor ISGF-3: one gene encodes the 91-and 84-kDa ISGF-3 proteins that are activated by interferon alpha. Proc Natl Acad Sci USA 89:7836-7839.
28. Shi Q, Xiong Q, Le X, Xie K. 2001. Regulation of interleukin-8 expression by tumor-associated stress factors. J Interferon Cytokine Res 21:553-566.
29. Strieter RM, Belperio JA, Burdick MD, Sharma S, Dubinett SM, Keane MP. 2004. CXC chemokines: angiogenesis, immunoangiostasis, and metastases in lung cancer. Ann NY Acad Sci 1028:351-360.
30. Wakabayashi K, Kambe F, Cao X, Murakami R, Mitsuyama H, Nagaya T, Saito K, Yoshida J, Seo H. 2004. Inhibitory effects of cyclosporin A on calcium mobilization-dependent interleukin-8 expression and invasive potential of human glioblastoma U251MG cells. Oncogene 23:6924-6932.
31. Wen Z, Zhong Z, Darnell JE Jr. 1995. Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 82:241-250.
32. Xie K. 2001. Interleukin-8 and human cancer biology. Cytokine Growth Factor Rev 12:375-391.
33. Yoshimura T, Matsushima K, Tanaka S, Robinson EA, Appella E, Oppenheim JJ, Leonard EJ. 1987. Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. Proc Natl Acad Sci USA 84:9233-9237.
34. Zhao X, Nozell S, Ma Z, Benveniste EN. 2007. The interferon-stimulated gene factor 3 complex mediates the inhibitory effect of interferon-β on matrix metalloproteinase-9 expression. FEBS J 274:6456-6468.